List of HealthPartners patents

Patents where

Current Assignee

Name

HealthPartners

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7618615 Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia	Patent 7618615 was granted and assigned to HealthPartners on November, 2009 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	7618615	November 17, 2009
‌ US Patent D934884 Display screen with graphical user interface	Patent D934884 was granted and assigned to HealthPartners on November, 2021 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	D934884	November 2, 2021
‌ US Patent D939540 Display screen with graphical user interface	Patent D939540 was granted and assigned to HealthPartners on December, 2021 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	D939540	December 28, 2021
‌ US Patent 7786166 Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent	Patent 7786166 was granted and assigned to HealthPartners on August, 2010 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	7786166	August 31, 2010
‌ US Patent 11013873 Methods for treating patients with impaired awareness of hypoglycemia	Patent 11013873 was granted and assigned to HealthPartners on May, 2021 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	11013873	May 25, 2021
‌ US Patent 9629819 Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9629819 was granted and assigned to HealthPartners on April, 2017 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9629819	April 25, 2017
‌ US Patent 7776312 Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity	Patent 7776312 was granted and assigned to HealthPartners on August, 2010 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	7776312	August 17, 2010
‌ US Patent 9707193 Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9707193 was granted and assigned to HealthPartners on July, 2017 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9707193	July 18, 2017
‌ US Patent 9345676 Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9345676 was granted and assigned to HealthPartners on May, 2016 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9345676	May 24, 2016
‌ US Patent 9351927 Pharmaceutical compositions for treatment of patients with neurodegeneration following ischemic insult	Patent 9351927 was granted and assigned to HealthPartners on May, 2016 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	9351927	May 31, 2016
‌ US Patent 9636312 Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9636312 was granted and assigned to HealthPartners on May, 2017 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9636312	May 2, 2017
‌ US Patent 9636313 Method of treating spinal cord injury comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9636313 was granted and assigned to HealthPartners on May, 2017 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9636313	May 2, 2017
‌ US Patent 9801835 Method of pre-treating patients for stroke comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9801835 was granted and assigned to HealthPartners on October, 2017 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9801835	October 31, 2017
‌ US Patent 10098928 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system	Patent 10098928 was granted and assigned to HealthPartners on October, 2018 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	10098928	October 16, 2018
‌ US Patent 9808509 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system	Patent 9808509 was granted and assigned to HealthPartners on November, 2017 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	9808509	November 7, 2017
‌ US Patent 9216161 Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9216161 was granted and assigned to HealthPartners on December, 2015 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9216161	December 22, 2015
‌ US Patent 9205066 Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity	Patent 9205066 was granted and assigned to HealthPartners on December, 2015 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9205066	December 8, 2015
‌ US Patent 7972595 Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog	Patent 7972595 was granted and assigned to HealthPartners on July, 2011 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	7972595	July 5, 2011
‌ US Patent 9211272 Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9211272 was granted and assigned to HealthPartners on December, 2015 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9211272	December 15, 2015
‌ US Patent 9211273 Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity	Patent 9211273 was granted and assigned to HealthPartners on December, 2015 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	9211273	December 15, 2015
‌ US Patent 8772263 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions	Patent 8772263 was granted and assigned to HealthPartners on July, 2014 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	8772263	July 8, 2014
‌ US Patent 9072756 Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog	Patent 9072756 was granted and assigned to HealthPartners on July, 2015 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	9072756	July 7, 2015
‌ US Patent 8765711 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage	Patent 8765711 was granted and assigned to HealthPartners on July, 2014 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	8765711	July 1, 2014
‌ US Patent 8771681 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection	Patent 8771681 was granted and assigned to HealthPartners on July, 2014 by the United States Patent and Trademark Office.		HealthPartners	United States Patent and Trademark Office	8771681	July 8, 2014
‌ US Patent 10092630 Methods of treating anorexia nervosa by intranasal administration of insulin	Patent 10092630 was granted and assigned to HealthPartners on October, 2018 by the United States Patent and Trademark Office.	HealthPartners	HealthPartners	United States Patent and Trademark Office	10092630	October 9, 2018

Results per page:

26 results

0 selected

26 results

0 selected